| CANDRIAM EQUITIES L BIOTECHNOLOGY R-H CAP EUR | BIOTECNOLOGÍA | 285,410000 | 13/02/2026 | 1,69% | 47,62% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY V CAP USD | BIOTECNOLOGÍA | 2.479,742033 | 13/02/2026 | 1,07% | 40,17% | *** |
| CANDRIAM EQUITIES L EMERGING MARKETS C CAP EUR | RVI EMERGENTES | 1.348,950000 | 13/02/2026 | 11,14% | 51,57% | **** |
| CANDRIAM EQUITIES L EMERGING MARKETS C DIS EUR | RVI EMERGENTES | 834,270000 | 13/02/2026 | 11,14% | 40,48% | ** |
| CANDRIAM EQUITIES L EMERGING MARKETS C-H CAP USD | RVI EMERGENTES | 247,167425 | 13/02/2026 | 10,40% | 43,83% | *** |
| CANDRIAM EQUITIES L EMERGING MARKETS I CAP EUR | RVI EMERGENTES | 1.634,700000 | 13/02/2026 | 11,20% | 56,40% | **** |
| CANDRIAM EQUITIES L EMERGING MARKETS I-H CAP USD | RVI EMERGENTES | 1.733,999326 | 13/02/2026 | 10,54% | · | ND |
| CANDRIAM EQUITIES L EMERGING MARKETS N CAP EUR | RVI EMERGENTES | 1.201,970000 | 13/02/2026 | 11,10% | 50,16% | *** |
| CANDRIAM EQUITIES L EMERGING MARKETS R CAP EUR | RVI EMERGENTES | 233,230000 | 13/02/2026 | 11,27% | 55,86% | **** |
| CANDRIAM EQUITIES L EMERGING MARKETS V CAP EUR | RVI EMERGENTES | 1.687,710000 | 13/02/2026 | 11,33% | 58,36% | **** |